Mindray Medical International Limited (NYSE:MR), a leading Chinese medical device manufacturer, recently revealed that it has agreed to buy a majority holding in Hunan Changsha Tiandiren Biotech Co., Ltd. (“TDR”). The terms of the deal were not revealed as the agreement is not material to Mindray’s financial results.
TDR is a Chinese producer of microbiology analysis offerings focused on microbial identification, antibiotic susceptibility testing (“ID/AST”) as well as blood culture system. … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here